Literature DB >> 17702640

The role of the interferon regulatory factor (IRF) family in dendritic cell development and function.

Lucia Gabriele1, Keiko Ozato.   

Abstract

Dendritic cells (DCs) are powerful sensors of foreign pathogens as well as cancer cells and provide the first line of defence against infection. They also serve as a major link between innate and adaptive immunity. Immature DCs respond to incoming danger signals and undergo maturation to produce high levels of proinflammatory cytokines including type I interferons (IFNs) to establish innate immunity. They then present antigens to T lymphocytes to stimulate lasting specific immune responses. Recent studies point to the importance of DCs in the induction of peripheral tolerance. Transcription factors of the IRF family have emerged as crucial controllers of many aspects of DC activity, playing an essential role in the establishment of early innate immunity. Furthermore, eight of the nine members of the IRF family have been shown to control either the differentiation and/or the functional activities of DCs. In this review, we focus on three aspects of DC properties that are under the control of IRFs: (1) the development and differentiation, (2) maturation in response to toll-like receptor (TLR) signalling and the production of anti-microbial cytokines, and (3) activation and expansion of lymphocytes to generate protective or tolerogenic immune responses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17702640     DOI: 10.1016/j.cytogfr.2007.06.008

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  34 in total

Review 1.  IRF7: activation, regulation, modification and function.

Authors:  S Ning; J S Pagano; G N Barber
Journal:  Genes Immun       Date:  2011-04-14       Impact factor: 2.676

2.  Role of IRF4 in IFN-stimulated gene induction and maintenance of Kaposi sarcoma-associated herpesvirus latency in primary effusion lymphoma cells.

Authors:  Adriana Forero; Patrick S Moore; Saumendra N Sarkar
Journal:  J Immunol       Date:  2013-06-26       Impact factor: 5.422

Review 3.  IRF8 regulates myeloid and B lymphoid lineage diversification.

Authors:  Hongsheng Wang; Herbert C Morse
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

4.  The remarkable capacity for gut microbial and host interactions.

Authors:  Dorottya Nagy-Szakal; Richard Kellermayer
Journal:  Gut Microbes       Date:  2011-05-01

Review 5.  Tumor-induced myeloid dysfunction and its implications for cancer immunotherapy.

Authors:  Michelle N Messmer; Colleen S Netherby; Debarati Banik; Scott I Abrams
Journal:  Cancer Immunol Immunother       Date:  2014-11-29       Impact factor: 6.968

6.  The transcription factor Fli-1 regulates monocyte, macrophage and dendritic cell development in mice.

Authors:  Eiji Suzuki; Sarah Williams; Shuzo Sato; Gary Gilkeson; Dennis K Watson; Xian K Zhang
Journal:  Immunology       Date:  2013-07       Impact factor: 7.397

7.  Differential expression of IRF8 in subsets of macrophages and dendritic cells and effects of IRF8 deficiency on splenic B cell and macrophage compartments.

Authors:  Chen-Feng Qi; Zhaoyang Li; Mark Raffeld; Hongsheng Wang; Alexander L Kovalchuk; Herbert C Morse
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

8.  Early secreted antigenic target of 6-kDa protein of Mycobacterium tuberculosis primes dendritic cells to stimulate Th17 and inhibit Th1 immune responses.

Authors:  Xisheng Wang; Peter F Barnes; Fangfang Huang; Ivana B Alvarez; Pierre F Neuenschwander; David R Sherman; Buka Samten
Journal:  J Immunol       Date:  2012-08-17       Impact factor: 5.422

9.  Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells.

Authors:  Brian T Edelson; Wumesh KC; Richard Juang; Masako Kohyama; Loralyn A Benoit; Paul A Klekotka; Clara Moon; Jörn C Albring; Wataru Ise; Drew G Michael; Deepta Bhattacharya; Thaddeus S Stappenbeck; Michael J Holtzman; Sun-Sang J Sung; Theresa L Murphy; Kai Hildner; Kenneth M Murphy
Journal:  J Exp Med       Date:  2010-03-29       Impact factor: 14.307

10.  The origin and development of nonlymphoid tissue CD103+ DCs.

Authors:  Florent Ginhoux; Kang Liu; Julie Helft; Milena Bogunovic; Melanie Greter; Daigo Hashimoto; Jeremy Price; Na Yin; Jonathan Bromberg; Sergio A Lira; E Richard Stanley; Michel Nussenzweig; Miriam Merad
Journal:  J Exp Med       Date:  2009-12-14       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.